Comparative evaluation of the efficacy and safety of crisaborole ointment (2%) versus tacrolimus ointment (0.1%) for the topical treatment of atopic dermatitis: an open-labeled single-blinded randomized controlled trial

被引：0
|
作者：
Chakraborty, Disha [1 ]
De, Abhishek [2 ]
Khan, Azhar [2 ]
Dhar, Sandipan [3 ]
Raychaudhuri, Siba P. [4 ,5 ,6 ]
机构：
[1] Sacramento VA Med Ctr, Dept Dermatol & Clin Immunol, Mather, CA USA
[2] Calcutta Natl Med Coll & Hosp, Dept Dermatol, Kolkata, India
[3] Inst Child Hlth Kolkata, Pediat Dermatol, Kolkata, India
[4] Univ Calif Davis, Dept Dermatol, Davis, CA USA
[5] Univ Calif Davis, Sch Med, Dept Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA USA
[6] VA Northern Calif Hlth Care Syst, Rheumatol, Sacramento, CA USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2024年
关键词：
crisaborole; phosphodiesterase-4; inhibitor; topical calcineurin inhibitor; tacrolimus; atopic dermatitis; eczema;
D O I：
10.1111/ijd.17572
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：402 / 404
页数：3
相关论文
共 50 条
  • [21] Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open-Label Phase 2a Study
    Tom, Wynnis L.
    Van Syoc, Merrie
    Chanda, Sanjay
    Zane, Lee T.
    PEDIATRIC DERMATOLOGY, 2016, 33 (02) : 150 - 159
  • [22] Side-by-Side Comparative Study of a Moisturizer and Topical Tacrolimus for Treating Mild to Moderate Atopic Dermatitis: A Randomized Single-Blinded Clinical Trial
    Shim, Joonho
    Jung, Yeon Joo
    Oh, Se Jin
    Lee, Jong Hee
    Park, Jihye
    DERMATOLOGIC THERAPY, 2023, 2023
  • [23] A Phase 2, Randomized, Controlled, Dose-Ranging Study Evaluating Crisaborole Topical Ointment, 0.5% and 2% in Adolescents With Mild to Moderate Atopic Dermatitis
    Gold, Linda F. Stein
    Spelman, Lynda
    Spellman, Mary C.
    Hughes, Matilda H.
    Zane, Lee T.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (12) : 1394 - 1399
  • [24] Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
    Paller, Amy S.
    Tom, Wynnis L.
    Lebwohl, Mark G.
    Blumenthal, Robin L.
    Boguniewicz, Mark
    Call, Robert S.
    Eichenfield, Lawrence F.
    Forsha, Douglass W.
    Rees, William C.
    Simpson, Eric L.
    Spellman, Mary C.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Hughes, Matilda H.
    Zane, Lee T.
    Hebert, Adelaide A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (03) : 494 - +
  • [25] Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream
    Kathuria, Sushruta
    Khaitan, Binod K.
    Ramam, M.
    Sharma, Vinod K.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2012, 78 (01): : 68 - 73
  • [26] A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis
    Neumann, Ella
    Amtage, Dorothee
    Bruckner-Tuderman, Leena
    Mockenhaupt, Maja
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2008, 6 (07): : 548 - 554
  • [27] The Efficacy and Safety of Jaungo, a Traditional Medicinal Ointment, in Preventing Radiation Dermatitis in Patients with Breast Cancer: A Prospective, Single-Blinded, Randomized Pilot Study
    Kong, Moonkyoo
    Hwang, Deok-Sang
    Lee, Jee Young
    Yoon, Seong Woo
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [28] A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis
    Reitamo, S
    Ortonne, JP
    Sand, C
    Cambazard, F
    Bieber, T
    Fölster-Holst, R
    Vena, G
    Bos, JD
    Fabbri, P
    Larsen, CG
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) : 1282 - 1289
  • [29] Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis - Review of randomised, double-blind clinical studies conducted in Japan
    Nakagawa, Hidemi
    CLINICAL DRUG INVESTIGATION, 2006, 26 (05) : 235 - 246
  • [30] Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
    Dupuis-Girod, Sophie
    Fargeton, Anne-Emmanuelle
    Grobost, Vincent
    Riviere, Sophie
    Beaudoin, Marjolaine
    Decullier, Evelyne
    Bernard, Lorraine
    Breant, Valentine
    Colombet, Bettina
    Philouze, Pierre
    Bailly, Sabine
    Faure, Frederic
    Hermann, Ruben
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
12345